Medtronic’s diabetes business MiniMed looks for $784m in US IPO
Diabetes specialist MiniMed has launched an initial public offering (IPO) to bolster its capital reserve amid its ongoing split from…
All articles by Annabel Kartal Allen
Annabel Kartal Allen
Annabel Kartal-Allen is a reporter for Clinical Trials Arena, Pharmaceutical Technology and Medical Device Network based in London, UK. Annabel holds interests in oncology, neurology and metabolic diseases. She has previous experience reporting for both the pharmaceutical and nutraceutical industries, and holds a BSc in Biology from the University of Sussex. Contact Annabel
-
-
MiraDx expands predictive oncology testing arsenal with Prostox Standard
California-based molecular diagnostics company MiraDx has added Prostox Standard to its portfolio – marking another US launch in the company’s…
-
Guardant Health acquires MetaSight amid positive 2026 financial outlook
Cancer diagnostics specialist Guardant Health has completed its $149m acquisition of health technology company, MetaSight Diagnostics, as the company gears…
-
Medical device testing in UK rises amid global competitiveness push
The Medicines and Healthcare products Regulatory Agency (MHRA) has revealed a record number of device trial approvals in the UK…
-
UK government champions healthtech through new NHS access programme
The UK government has set out to improve access to healthcare technology within the National Health Service (NHS) through the…
-
UK’s NICE greenlights Abbott’s CardioMEMS heart failure sensor
The UK’s National Institute for Health and Care Excellence (NICE) has recommended medtech giant Abbott’s heart failure sensor CardioMEMS. This…
-
Artivion’s aortic stents boost post-surgical outcomes in interventional studies
Artivion has debuted long-term clinical data on two of its cardiac stent products, revealing each’s solution’s potential to offer extended…
-
Abbott touts neuromodulation portfolio’s long-term benefits
Abbott has touted the potential of its neuromodulation portfolio in reducing patient and healthcare burdens associated with chronic pain following…
-
CellBxHealth’s new CEO pivots strategy amid financial turnaround efforts
CellBxHealth’s CEO Peter Collins has explained plans to restructure the company following its rebrand from ANGLE in October. The company…
-
Olympus lets 2,000 staff go in endoscopy restructuring initiative
Olympus has initiated a plan to restructure its endoscopy business, following numerous regulatory run-ins and controversy within the company’s leadership…